Questions, Feedback & Help
Send us an email and we'll get back to you ASAP. Or you can read our Frequently Asked Questions.
  • page settings
  • hide sidebar
  • show empty fields
  • layout
  • (too narrow)
  • open all
  • close all
Resources » Paper

Parrilla A et al. (2016) Cell Cycle "Mitotic entry: The interplay between Cdk1, Plk1 and Bora."

  • History

  • Referenced

  • Tree Display

  • My Favorites

  • My Library

  • Comments on Parrilla A et al. (2016) Cell Cycle "Mitotic entry: The interplay between Cdk1, Plk1 and Bora." (0)

  • Overview

    PMID:
    Status:
    Publication type:
    Journal_article
    WormBase ID:
    WBPaper00051004

    Parrilla A, Cirillo L, Thomas Y, Gotta M, Pintard L, & Santamaria A (2016). Mitotic entry: The interplay between Cdk1, Plk1 and Bora. Cell Cycle, 1-6. doi:10.1080/15384101.2016.1249544

    Polo-like kinase 1 (Plk1) is an important mitotic kinase that is crucial for entry into mitosis after recovery from DNA damage-induced cell cycle arrest. Plk1 activation is promoted by the conserved protein Bora (SPAT-1 in C. elegans), which stimulates the phosphorylation of a conserved residue in the activation loop by the Aurora A kinase. In a recent article published in Cell Reports, we show that the master mitotic kinase Cdk1 contributes to Plk1 activation through SPAT-1/Bora phosphorylation. We identified 3 conserved Sp/Tp residues that are located in the N-terminal, most conserved part, of SPAT-1/Bora. Phosphorylation of these sites by Cdk1 is essential for Plk1 function in mitotic entry in C. elegans embryos and during DNA damage checkpoint recovery in mammalian cells. Here, using an untargeted Forster Resonance Energy Transfer (FRET) biosensor to monitor Plk1 activation, we provide additional experimental evidence supporting the importance of these phosphorylation sites for Plk1 activation and subsequent mitotic entry after DNA damage. We also briefly discuss the mechanism of Plk1 activation and the potential role of Bora phosphorylation by Cdk1 in this process. As Plk1 is overexpressed in cancer cells and this correlates with poor prognosis, understanding how Bora contributes to Plk1 activation is paramount for the development of innovative therapeutical approaches.


    Tip: Seeing your name marked red? Please help us identify you.